MTUS1 and cancer: Downregulation of MTUS1 has been demonstrated in various human cancers, including pancreatic [3], ovarian [11], head and neck [7,12], colorectal [13], breast [14], bladder [15], stomach [16], lung [17], gallbladder [18], and kidney (renal cell carcinoma) [19] cancers.